| |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Previous Article | Next Article ![]()
Clinical and Vaccine Immunology, April 2008, p. 732-734, Vol. 15, No. 4
1071-412X/08/$08.00+0 doi:10.1128/CVI.00014-08
Copyright © 2008, American Society for Microbiology. All Rights Reserved.

Liver Unit,1 Biochemistry Departament, Hospital Universitario Valle Hebron and CIBER-EHD of Instituto Carlos III, Passeig Vall d'Hebron 119-121, 08035 Barcelona, Spain,5 Directorate of Public Health, Generalitat of Catalonia,2 CIBER Epidemiology and Public Health (CIBERESP), Cr Roc Boronat 81-95, 08005 Barcelona, Spain,3 Department of Public Health, University of Barcelona, Cr Casanovas 143, 08036 Barcelona, Spain4
Received 14 January 2008/ Returned for modification 28 January 2008/ Accepted 18 February 2008
The prevalence of immunoglobulin G (IgG) anti-hepatitis E virus (anti-HEV) antibodies was studied with a representative sample of 1,249 healthy children aged between 6 and 15 years. IgG anti-HEV antibodies were detected in 57 (4.6%) of the 1,249 samples analyzed, suggesting that some children are exposed to HEV in early childhood.
Published ahead of print on 5 March 2008.
| Antimicrob. Agents Chemother. | Clin. Microbiol. Rev. | Infect. Immun. |
|---|---|---|
| J. Clin. Microbiol. | J. Virol. | ALL ASM JOURNALS |